Dermatomyositis

Lancet

Volumn 355, Issue 9197, 2000, Pages 53-57

  Callen, Jeffrey P ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM OXIDE; ANTIBODY; ANTIMALARIAL AGENT; AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DILTIAZEM; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MEPACRINE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; WARFARIN;

ALOPECIA; ARTHRALGIA; ARTHRITIS; CALCINOSIS; CUTICLE; DERMATOMYOSITIS; ERYTHEMA; ESOPHAGUS DISEASE; HEART DISEASE; HUMAN; MYOPATHY; OVARY CANCER; PAPULE; PATHOGENESIS; POIKILODERMA; PRIORITY JOURNAL; PROGNOSIS; RASH; SHORT SURVEY; SIDE EFFECT; SKIN MANIFESTATION; TELANGIECTASIA;

EID: 0033959857     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)05157-0     Document Type: Review

References (36)

1. Targoff I.N. Dermatomyositis and polymyositis. Curr Probl Dermatol. 3:1991;131-180.
2. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 344-47, 403-07.
3. Dalakas M.C. Molecular immunology and genetics of inflammatory muscle diseases. Arch Neurol. 54:1998;1509-1512.
4. Lundberg I.E., Nyberg P. New developments in the role of cytokines and chemokines in inflammatory myopathies. Curr Opin Rheumatol. 10:1998;521-529.
5. Bohan A., Peter J.B., Bowman R.L., Pearson C.M. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine. 56:1977;255-286.
6. Euwer R.L., Sontheimer R.D. Amyopathic DM (DM siné myositis). J Am Acad Dermatol. 24:1991;959-966.
7. Sayers M.E., Chou S.M., Calabrese L.H. Inclusion body myositis: analysis of 32 cases. J Rheumatol. 19:1992;1385-1389.
8. Siguregeirsson B., Lindelöf B., Edhag O., Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. N Engl J Med. 325:1992;363-367.
9. Kasteler J.S., Callen J.P. Scalp involvement in dermatomyositis: often overlooked or misdiagnosed. JAMA. 272:1994;1939-1941.
10. Rockerbie N.R., Woo T.Y., Callen J.P., Giustina T. Cutaneous changes of dermatomyositis precede muscle weakness. J Am Acad Dermatol. 20:1989;629-632.
11. Stonecipher M.R., Jorizzo J.L., White W.L., Walker F.O., Prichard E. Cutaneous changes of dermatomyositis in patients with normal muscle enzymes: DM siné myositis? J Am Acad Dermatol. 28:1993;951-956.
12. Cosnes A., Amaudric F., Gherardi R.et al. Dermatomyositis without muscle weakness: long-term follow-up of 12 patients without systemic corticosteroids. Arch Dermatol. 131:1995;1381-1385.
13. Cheong W.K., Hughes G.R.V., Norris P.G., Hawk J.L.M. Cutaneous photosensitivity in dermatomyositis. Br J Dermatol. 131:1994;205-208.
14. Wortman R.L. Polymyositis and dermatomyositis. Curr Pract Med. 2:1999;167-174.
15. Spiera R., Kagen L. Extramuscular manifestations in idiopathic inflammatory myopathies. Curr Opin Rheumatol. 10:1998;556-561.
16. Marie I., Hatron P.-Y., Hachulla E., Wallaert B., Michon-Pasturel U., Devulder B. Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol. 25:1998;1336-1343.
17. Gonzalez-Lopez L., Gamez-Nava J.I., Sanchez L.et al. Cardiac manifestations in dermato-polymyositis. Clin Exp Rheumatol. 14:1996;373-379.
18. Chow W.H., Gridley G., Mellemkjaer L., McLaughlin J.K., Olsen J.H., Fraumeni J.F. Jr. Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Cancer Causes Control. 5:1995;9-13.
19. Airio A, Pukkala E, Isomäki. Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol 1995; 22: 1300-1303.
20. Whitmore S.E., Rosenshein N.B., Provost T.T. Ovarian cancer in patients with dermatomyositis. Medicine. 73:1994;153-160.
21. Peng J.-C., Sheem T.-S., Hsu M.-M. Nasopharyngeal carcinoma with dermatomyositis: analysis of 12 cases. Arch Otolaryngol Head Neck Surg. 121:1995;1298-1301.
22. Pachman L.M. An update on juvenile dermatomyositis. Curr Opin Rheumatol. 7:1995;437-441.
23. Daoud M.S., Gibson L.E., Pittelkow M.R. Hydroxyurea dermopathy: a unique lichenoid eruption complicating long-term therapy with hydroxyurea. J Am Acad Dermatol. 36:1997;178-182.
24. Grob J.J., Collet A.M., Bonerandi J.J. Dermatomyositis-like syndrome induced by nonsteroidal anti-inflammatory agents. Dermatologica. 178:1989;58-59.
25. Love L.A., Leff R.L., Fraser D.D.et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine. 70:1991;360-374.
26. Callen J.P. The value of malignancy evaluation in patients with dermatomyositis. J Am Acad Dermatol. 6:1982;253-259.
27. Villalba L., Adams E.M. Update on therapy for refractory dermatomyositis and polymyositis. Curr Opin Rheumatol. 8:1996;544-551.
28. Villalba L., Hicks J.E., Adams E.M.et al. Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens. Arthritis Rheum. 41:1998;392-399.
29. Miller F.W., Leitman S.F., Cronin M.et al. Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med. 326:1992;1380-1384.
30. Dalakas M.C., Illa I., Dambrosia J.M.et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med. 329:1993;1993-2000.
31. Woo T.Y., Callen J.P., Voorhees J.J., Bickers D.R., Hanno R., Hawkins C. Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine. J Am Acad Dermatol. 10:1984;592-600.
32. Zieglschmid-Adams M.E., Pandya A.G., Cohen S.B., Sontheimer R.D. Treatment of dermatomyositis with methotrexate. J Am Acad Dermatol. 32:1995;754-757.
33. Kasteler J.S., Callen J.P. Low-dose methotrexate administered weekly in an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis. J Am Acad Dermatol. 36:1997;67-71.
34. Callen A.M., Pachman L.M., Hayford J., Chung A., Ramsey-Goldman R. Intermittent high dose intravenous methylprednisolone (IV pulse) prevents calcinosis and shortens disease course in juvenile dermatomyositis (JDMS). Arthritis Rheum. 37:1994;10. (abstr).
35. Oliveri M.B., Palermo R., Mautalen C., Hübscher O. Regression of calcinosis during Diltiazem treatment of juvenile dermatomyositis. J Rheumatol. 23:1996;2152-2155.
36. Marie I., Hatron P.-Y., Levesque H.et al. Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine. 78:1999;139-147.